In this episode of ‪ChromatographyTalk‬, ‪Organomation‬ General Manager David Oliva sits down with Imad Haidar Ahmad, Scientific Research Director at Amgen leading separations for Discovery Chemistry and Externalization. Imad's career spans Novartis, Merck, and now Amgen, and his research on computer-assisted method development has landed multiple front covers in Analytical Chemistry.We dig into how his group builds retention models from as few as nine lab experiments to map an entire separation landscape — replacing weeks of trial and error with a resolution map you can query and rebuild from. Imad breaks down where this modeling approach struggles (large molecules, SFC, fully autonomous method development), walks through two-dimensional liquid chromatography in plain terms for anyone who's only worked in 1D, and shares the story behind his group's greenness-score mapping work — including where swapping acetonitrile for methanol worked, and where it didn't.We also talk career advice: what a typical day looks like leading a discovery-stage separations team, how undergrad and grad students can bridge the academia-to-industry gap, and what Imad sees as the field's biggest unsolved problem.<h3>Video Transcription</h3>Chromatographic method development is increasingly moving beyond trial and error toward workflows built on modeling, automation, multidimensional separations, and smarter use of data. In a recent interview, Haidar Ahmad discussed how these approaches are changing pharmaceutical analysis, why understanding the fundamentals of chromatography remains essential, and where some of the biggest opportunities in separation science still lie.Ahmad’s route into analytical chemistry was not entirely planned. As an undergraduate, he initially found inorganic and organic chemistry particularly attractive, but a final-year project focused on the analysis of additives in bread introduced him to the possibilities of analytical chemistry. During his PhD, his research moved into polymer analysis and structure–property relationships. His interest in chromatography deepened when he encountered two-dimensional liquid chromatography (2D-LC), particularly its ability to reveal forms of polymer heterogeneity that could not be adequately characterized using a single separation technique. This eventually led to postdoctoral work with Peter Carr, where Ahmad focused on chromatographic separations and the fundamentals of chromatography.His subsequent career in the pharmaceutical industry exposed him to different stages of drug development, from late-stage method development and validation to drug substance characterization, purification, and finally discovery-stage separations. That breadth of experience has shaped his view of chromatography as both a scientific discipline and a practical problem-solving tool. In late-stage development, the objective may be a highly robust method capable of successful validation and transfer between laboratories. In discovery, by contrast, speed becomes critical because teams may be working with thousands of molecules while trying to identify the best candidates to advance.&nbsp;<h4>Discovery-stage chromatography: speed, prioritization, and throughput</h4>For a separations team supporting drug discovery, the working day is shaped by a constant flow of requests from medicinal chemistry and other partner groups. The challenge is not simply to perform the analyses, but to decide which requests are most urgent, remove bottlenecks, communicate with project teams, and continuously improve existing workflows.According to Ahmad, one of the most important questions is whether a task can be done faster or in a more high-throughput way. Discovery laboratories operate under strong time pressure, and efficiency therefore becomes part of the scientific strategy rather than merely an operational concern. As he describes it, the work combines science, prioritization, leadership, and communication, all with the aim of moving the most important projects forward as quickly as possible.<h4>In silico modeling: letting the computer perform the experiments</h4>One of the central themes of Ahmad’s work is in silico chromatographic modeling. In practical terms, the approach begins with a carefully designed set of laboratory experiments—often around nine runs. The resulting data are fed into software that builds retention models describing how analyte retention changes with variables such as mobile-phase composition and temperature.The software can then generate a resolution map representing a much larger separation space than could realistically be tested experimentally. Instead of running dozens or hundreds of conditions by trial and error, the analyst can identify regions where critical peak pairs are predicted to achieve the best separation.For Ahmad, the value of these maps goes beyond simply finding the condition with the highest resolution. Each point on the map represents a chromatographic condition, while the visual output shows where poor and strong separations are expected. A broad region of good resolution is particularly useful because it points toward a more robust operating space rather than a narrowly defined optimum that might be sensitive to small variations in experimental conditions.He therefore prefers to think of a chromatographic model as a map or database, rather than simply an optimization tool. If an impurity later disappears from the process, the corresponding peak can be removed from the model and new conditions selected without repeating the complete experimental study. Conversely, if a new degradation product appears during stability studies, the peak can be added and the existing model used to search for updated separation conditions.<h4>Why trial and error still has a place</h4>Modeling does not mean that conventional trial-and-error method development has disappeared. Ahmad points out that it remains useful in early discovery, particularly for fit-for-purpose methods where speed is more important than achieving a fully optimized separation.The situation changes later in development. A method intended for validation, transfer, or long-term routine use carries much greater risk. Trial and error may identify a condition that appears satisfactory without revealing whether it represents the most robust region of the separation space. If that method later fails during transfer or routine operation, the consequences can be costly.For late-stage methods, the additional investment required to build a model can therefore reduce risk over the much longer lifetime of the analytical procedure.<h4>Models are only as good as the experiments behind them</h4>Chromatographic modeling is not automatic proof against poor method development. Ahmad compares the technology to a GPS: it is highly useful, but only if the analyst understands where they are trying to go.Careful experimental design remains essential. Incorrect dwell-volume or column-volume information, as well as insufficient column re-equilibration, can produce misleading predictions. Importantly, these problems may not be obvious when the experimental runs used to construct the model are compared with their calculated values. They may emerge only when the software begins predicting new conditions within the modeled design space.Modeling is also easier for some separations than others. Ahmad describes reversed-phase LC of small molecules as comparatively straightforward, while large biomolecules are more challenging because their retention can be highly sensitive to small changes in mobile-phase composition and temperature.Other separation modes present additional difficulties. Ahmad notes that his teams have found supercritical fluid chromatography (SFC) particularly challenging to model successfully. Fully autonomous method development remains another unresolved goal: current tools can automate parts of optimization, but analyst input is still required.<h4>Why two dimensions can reveal what one dimension cannot</h4>Ahmad’s early interest in 2D-LC came from polymer characterization. He explains the principle simply: one-dimensional chromatography may answer one question about a sample, while two complementary dimensions can answer two.Two copolymers, for example, may have similar molecular size and therefore coelute in size-exclusion chromatography. A second separation mechanism based on interaction with a stationary phase may distinguish them according to chemical composition. Combining both dimensions provides a more complete description of complex distributions involving molecular weight, composition, sequence, and other forms of heterogeneity.Historically, the complexity of both instrumentation and software limited wider adoption of 2D-LC. Ahmad recalls systems requiring several computers and multiple software packages. That situation has improved substantially, and 2D-LC is now easier to implement across research and pharmaceutical development.Nevertheless, modeling multidimensional separations still presents challenges. While models can be built for individual fractions or dimensions, current software does not easily identify a common optimum across multiple models simultaneously. Much of this comparison still requires manual work.<h4>Bringing sustainability into method development</h4>Another area where Ahmad sees room for change is green analytical chemistry.Traditional pharmaceutical method development has understandably prioritized resolution, sensitivity, robustness, and turnaround time. Sustainability has often been treated as a secondary consideration, particularly at the analytical scale, where solvent use appears small compared with preparative chromatography or manufacturing.That mindset is beginning to change. Ahmad argues that greenness metrics should increasingly be incorporated directly into method-development software. If analysts could immediately see how changes in flow rate, gradient conditions, solvent choice, or other parameters affect the environmental profile of a method, sustainability could become part of routine optimization rather than an assessment performed after the method has already been developed.The objective, however, is not to pursue the greenest possible method regardless of analytical performance. Ahmad emphasizes the need to develop methods that are as green as possible while remaining fit for purpose. Modeling can potentially help balance these competing requirements by identifying conditions that preserve separation performance while allowing greener solvents or alternative chromatographic conditions to be introduced.<h4>Advice for young chromatographers: do not treat HPLC as a black box</h4>For students learning chromatography, Ahmad’s central recommendation is straightforward: do not treat the HPLC system as a black box.Rather than collecting chromatograms by making random changes, he encourages analysts to build a mental model of the separation. When temperature, gradient, or another parameter is changed, they should ask why retention or selectivity changed and use each experiment to improve their understanding of the system.He also recommends making use of educational resources on chromatographic fundamentals and method development and, importantly, not being afraid to experiment with instrument conditions. Modern systems are robust, but the analyst still needs to understand the underlying separation science in order to use them effectively.The same proactive attitude applies to career development. Ahmad strongly encourages students to seek industry internships and make connections beyond their own institutions. Conferences and poster sessions can provide natural opportunities to meet scientists from industry, discuss research, and ask about internship opportunities. Based on his own experience working with undergraduate and graduate interns, these collaborations can benefit both students and research teams and may strongly influence later academic or career decisions.<h4>What still needs to be solved?</h4>Asked about the biggest unresolved challenges in separation science, Ahmad does not begin with technology. Instead, he points to a shortage of well-trained analytical chemists with a strong understanding of chromatographic fundamentals.Alongside education, he identifies several technical opportunities. One is truly autonomous method development, where an instrument and software could optimize a separation without continuous analyst input. Another is the ability to predict chromatographic selectivity directly from molecular structure.Such capability could be especially valuable in high-throughput discovery environments. If a laboratory could predict which stationary phase and conditions were most likely to separate a particular set of compounds or isomers before entering the laboratory, method development could become considerably faster and more efficient.Taken together, Ahmad’s perspective points toward a future in which chromatography becomes increasingly model-driven, automated, multidimensional, and sustainability-aware. But the technology does not eliminate the need for chromatographic knowledge. On the contrary, as analytical tools become more powerful, understanding the fundamentals may become even more important—the software can explore the separation space, but the scientist still needs to know what question to ask and how to interpret the answer.<blockquote>This text has been automatically transcribed from a video presentation using AI technology. It may contain inaccuracies and is not guaranteed to be 100% correct.</blockquote><blockquote><h4>Concentrating on Chromatography Podcast</h4>Dive into the frontiers of chromatography, mass spectrometry, and sample preparation with host David Oliva. Each episode features candid conversations with leading researchers, industry innovators, and passionate scientists who are shaping the future of analytical chemistry. From decoding PFAS detection challenges to exploring the latest in AI-assisted liquid chromatography, this show uncovers practical workflows, sustainability breakthroughs, and the real-world impact of separation science. Whether you’re a chromatographer, lab professional, or researcher you'll discover inspiring content!You can find Concentrating on Chromatography Podcast in podcast apps:<ul><li><a target="_blank" rel="noopener noreferrer" href="https://open.spotify.com/show/1wZg67rCjoGju4yhqxI3tL">Spotify</a></li><li><a target="_blank" rel="noopener noreferrer" href="https://podcasts.apple.com/tz/podcast/concentrating-on-chromatography/id1788429185">Apple podcast</a></li><li><a target="_blank" rel="noopener noreferrer" href="https://podscan.fm/podcasts/concentrating-on-chromatography">podscan</a></li></ul>and on <a target="_blank" rel="noopener noreferrer" href="https://www.youtube.com/@ChromatographyTalk/videos">YouTube channel</a></blockquote>

 In Silico Modeling, 2D-LC & Green Chromatography: Imad Ahmad on the Future of Method Development

Proper care and maintenance of HPLC columns are essential for getting accurate results and saving on replacement costs. Extending the HPLC column life not only ensures consistent performance but also reduces downtime and the need for frequent replacements.Routine maintenance is equally essential for sustaining column functionality. Correct handling of the column is paramount, ensuring strict compliance with the manufacturer’s specifications regarding pressure, pH, flow rate, and temperature.In the next section, we will explore these best practices in greater detail, offering further guidance on essential HPLC column maintenance strategies. Whether you’re working in a high-throughput lab, or conducting occasional analyses, these strategies will help you get the most out of your <a target="_blank" rel="noopener noreferrer" href="https://labrulez.com/en-us/all/products?category=48&amp;manufacturerItems=50">HPLC columns</a>.<h3>Essential Guidelines for Extending HPLC Column Life</h3>By adopting these simple yet effective practices, you can greatly extend the HPLC column life while ensuring reliable, high-quality results in your analyses.<h4>Proper Column Handling</h4>HPLC columns should be handled with care to prevent physical damage or shock. The pump should not be started at high flow rates; instead, the flow rate should be gradually increased over several minutes. A pump pressure limit should be set to protect the column from over pressuring, as sudden pressure changes can lead to voids, negatively affecting the column’s performance.<h4>HPLC Column Conditioning and Equilibration</h4>Conditioning is a critical step for preparing a new or stored HPLC column by replacing the storage solvent with the desired mobile phase. Care must be taken to avoid introducing immiscible solvent mixtures into the column. Universally miscible solvents such as THF (tetrahydrofuran) or IPA (isopropyl alcohol) can be useful for this process when moving from normal phase to reversed phase solvent systems. Care must also be taken to ensure that solvents that may be damaging to a specific stationary phase are avoided.For example, if a reversed-phase column experiences phase collapse due to 100% aqueous mobile phases, it should be reactivated. This process involves running 100% acetonitrile at a high flow rate and a temperature as high as 60°C. It is essential to ensure no solid buffers precipitate from residual solvents. Depending on the column condition, between 50 and 100 column volumes are needed for complete reactivation and equilibration, restoring the column’s efficiency for future use.<h4>Optimizing Operating Conditions</h4>Optimizing operating conditions is paramount to enhancing HPLC column efficiency and prolonging their operational lifespan. A fundamental aspect of this is strict adherence to the manufacturer’s recommended temperature, pH and pressure parameters.Deviating from these limits, particularly by operating at elevated temperatures, can significantly hasten the degradation of the stationary phase and hardware, thereby compromising overall performance. Elevated temperatures can also narrow the pH operating range, exacerbating the risk of column degradation through phenomena such as peak broadening or diminished efficiency.Effective pressure management is equally crucial. Sudden pressure surges or mechanical shocks can result in bed voiding, leading to poor chromatographic performance, such as split peaks and reduced separation efficiency. Gradual ramping of flow and pressure, implemented each time the column is initiated, mitigates these risks. Many modern HPLC systems are equipped with automated flow-pressure ramping capabilities, ensuring smoother transitions and reducing the potential for column damage.In addition, vigilant monitoring of the mobile phase's pH is vital to the maintenance of HPLC column integrity. Deviations from the optimal pH range can cause significant harm to the stationary phase. For instance, leads to ligand hydrolysis which leads to a loss of stationary phase functionality and diminished column performance over time. High pH can lead to silica degradation. This weakens the silica structure, causing particle dissolution, void formation, and loss of column efficiency. Maintaining the pH within optimal boundaries is essential for preserving the column’s structural integrity and ensuring consistent chromatographic performance.Furthermore, incorporating inline filters and guard columns into the system serves as a proactive measure to prevent particulates and harsh sample matrices from damaging the analytical column. These preventive tools significantly enhance operational conditions and safeguard the column from contamination, ultimately contributing to extended HPLC column lifetime and reliable performance.<h4>Regular Column Maintenance</h4>Effective routine maintenance is paramount to extending the HPLC column lifetime and ensuring the consistent performance of HPLC columns. A critical aspect of this maintenance is the thorough washing of the column after each use to eliminate residual sample components and mobile phase contaminants.The cleaning process generally involves performing an isocratic or gradient wash using a solvent system similar to the one previously used on the column but substituting the buffer with HPLC-grade water. This helps effectively remove any residual buffer components from the column. This meticulous cleaning process is vital to preventing the accumulation of impurities that could compromise the stationary phase and lead to decreased efficiency over time.Post-cleaning, it is imperative to end-cap the column before storage to prevent the stationary phase from drying out, a condition that can negatively impact the column’s future performance. Proper capping or sealing ensures that the column remains in optimal condition, safeguarding its structural integrity and readiness for subsequent analyses.Additionally, utilizing an older HPLC system as a dedicated wash station can further streamline maintenance practices, freeing up live systems for active use. Consistently adhering to a rigorous cleaning and storage regimen not only enhances the longevity of HPLC columns but also guarantees the delivery of precise and reliable analytical results.For severe contamination or pressure buildup, backflushing may be necessary to dislodge tightly bound contaminants. However, backflushing should only be performed when absolutely necessary, as it can stress the column packing material. It is essential to consult the manufacturer’s instructions before attempting this method.

How to Extend the Lifetime of HPLC Columns?

Researchers from CATRIN at Palacký University, together with colleagues from VSB – Technical University of Ostrava and Charles University, have developed a new graphene ink for producing inexpensive and sensitive printed sensors. Using single-atom engineering, they incorporated copper atoms into the material, enabling highly sensitive detection of dopamine – a neurotransmitter responsible for transmitting signals between nerve cells. The approach, <a target="_blank" rel="noopener noreferrer" href="https://advanced.onlinelibrary.wiley.com/doi/10.1002/advs.76796">presented in the journal Advanced Science</a>, has strong potential for use in medical diagnostics.<img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/CATRIN_Atom_po_atomu_Vedci_ukazali_novy_smer_v_lekarske_diagnostice_8a02ad6a66.webp" alt="CATRIN: Atom by atom. Scientists reveal a new direction in medical diagnostics" srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_CATRIN_Atom_po_atomu_Vedci_ukazali_novy_smer_v_lekarske_diagnostice_8a02ad6a66.webp 117w," sizes="100vw" width="1920" height="2560">Single-atom engineering makes it possible to control the chemical reactivity of materials at the level of individual atoms. Its broader application in medical diagnostics has so far been limited by a lack of atomically engineered materials and printable inks based on them. Researchers have now developed a new class of single-atom-doped graphene materials as well as an ink for producing sensitive printed sensors. Copper proved particularly effective for dopamine detection, which is important for biomedical research and the development of advanced diagnostic technologies for diseases including Alzheimer’s disease.<img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/CATRIN_Atom_po_atomu_Vedci_ukazali_novy_smer_v_lekarske_diagnostice_2_97e419f039.webp" alt="CATRIN: Atom by atom. Scientists reveal a new direction in medical diagnostics" srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_CATRIN_Atom_po_atomu_Vedci_ukazali_novy_smer_v_lekarske_diagnostice_2_97e419f039.webp 117w," sizes="100vw" width="1920" height="2560">“The NGA-Cu ink we developed enables the production of fully inkjet-printed, sustainable paper-based electrodes at very low cost. Each sensor requires only 1.3 micrograms of active ink, costs approximately one Czech koruna and provided a stable response for at least three months. The ink is also fully compatible with commonly available materials inkjet printers. This creates significant potential for producing affordable, digitally designed sensors whose function can be tailored atom by atom,” said&nbsp;the corresponding author of the <a target="_blank" rel="noopener noreferrer" href="https://advanced.onlinelibrary.wiley.com/doi/10.1002/advs.76796">paper</a> Michal Otyepka.The basis for this new generation of single-atom inks was nitrogen-doped graphene acid (NGA), which CATRIN researchers developed several years ago. They have now progressively enriched it with different individual metal atoms, including copper, iron and manganese.<img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/CATRIN_Atom_po_atomu_Vedci_ukazali_novy_smer_v_lekarske_diagnostice_3_c15d831792.webp" alt="CATRIN: Atom by atom. Scientists reveal a new direction in medical diagnostics" srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_CATRIN_Atom_po_atomu_Vedci_ukazali_novy_smer_v_lekarske_diagnostice_3_c15d831792.webp 117w," sizes="100vw" width="1920" height="2560">“We found that the electrochemical response depends fundamentally on the type of atom used. While copper atoms significantly enhance the dopamine signal, other metals suppress it. What matters, therefore, is not only the presence of isolated metal atoms but also the specific metal involved. This is a very important finding for the further development of biosensors,” explained first author Martin-Alex Nalepa.The published results introduce a new class of sensing materials with considerable potential for medical diagnostics. The researchers present a broadly applicable platform for developing graphene inks containing individual metal atoms and open the way towards scalable, reproducible and material-efficient production of advanced electrochemical sensors.&nbsp;“We are only at the beginning and are fascinated by the new possibilities opening up before us. We can see that by changing the type of atom, we can control the sensitivity and selectivity of the sensor. In addition to dopamine, we can also determine immunoglobulins very precisely – antibodies whose levels and types may serve as important indicators of autoimmune or infectious diseases,” emphasised Radek Zbořil, a co-author of the paper.<img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/CATRIN_Atom_po_atomu_Vedci_ukazali_novy_smer_v_lekarske_diagnostice_4_273cd760a5.webp" alt="CATRIN: Atom by atom. Scientists reveal a new direction in medical diagnostics" srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_CATRIN_Atom_po_atomu_Vedci_ukazali_novy_smer_v_lekarske_diagnostice_4_273cd760a5.webp 117w," sizes="100vw" width="1920" height="2560">Electrochemical biosensors can find applications not only in medicine but also in food quality control, drinking-water monitoring and environmental pollution monitoring. Their key components are functionalised electrodes, and graphene-based materials have proved particularly suitable for their production. A key factor in the success of the Olomouc researchers was the targeted preparation of graphene ink with the required properties.The research was supported by the TECHSCALE project under the Johannes Amos Comenius Programme.<img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/CATRIN_Atom_po_atomu_Vedci_ukazali_novy_smer_v_lekarske_diagnostice_5_b1778f77f2.jpg" alt="CATRIN: Atom by atom. Scientists reveal a new direction in medical diagnostics: Project TECHSCALE (No. CZ.02.01.01/00/22_008/0004587) is financed by the MEYS OP JAC Excellent research programme, supported by ERDF/ESF." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_CATRIN_Atom_po_atomu_Vedci_ukazali_novy_smer_v_lekarske_diagnostice_5_b1778f77f2.jpg 245w," sizes="100vw" width="620" height="87"><blockquote><h4>Article</h4><h4><a target="_blank" rel="noopener noreferrer" href="https://advanced.onlinelibrary.wiley.com/doi/10.1002/advs.76796">Single-Atom-Enhanced Fully Inkjet-Printed Electrochemical Sensor for Dopamine Detection</a></h4>Martin-Alex Nalepa, David Panáček, Vítězslav Hrubý, Matěj Jendřišák, Rostislav Langer, Michal Langer, Petr Jakubec, Ivan Dědek, Vojtěch Kupka, Michal Mazur, Radek Zbořil, Michal OtyepkaAdv. Sci., 2026, e76796<a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1002/advs.76796">https://doi.org/10.1002/advs.76796</a><h6>licenced under <a target="_blank" rel="noopener noreferrer" href="https://creativecommons.org/licenses/by/4.0/">CC-BY 4.0</a></h6></blockquote><h4>Abstract</h4>Single-atom (SA) engineering offers atomic-level control over interfacial reactivity, yet the lack of printable SA-based inks hinders its practical translation into electrochemical sensing. Here, a fully water-based inkjet-printable ink is introduced based on nitrogen-doped graphene acid (NGA) hosting atomically dispersed Cu centers (NGA-Cu-ink). The ink enables digitally controlled, spatially defined deposition and fabrication of low-cost ($0.04 per sensor), fully inkjet-printed sustainable electrodes on paper. A comparison of NGA functionalized with different SA dopants (Cu, Mn, Fe, Ce) identifies a strong dopant-dependent electrochemical response, with Cu uniquely enhancing the analyte signal while other dopants suppress it, demonstrating that SA identity is a decisive design parameter in printed sensing interfaces profiling sensitivity and selectivity. The functional role of the NGA support is to provide dense anchoring sites (nitrogen and carboxylate groups) that stabilize atomically dispersed metal centers and create adsorption- and electron-transfer–active microenvironments. The NGA-Cu-ink yields enhanced dopamine oxidation, enabling quantitative detection on fully printed devices (limit of detection 9.7 µM; linear range 50–400 µM) and printed-on-electrode platforms (10.6 µM), while maintaining &lt;10% signal variation over 11 weeks. The approach establishes a general route to single-atom graphene-based inks for scalable, reproducible, and low-material-consumption manufacturing of advanced electrochemical sensors.

Atom by atom. Scientists reveal a new direction in medical diagnostics

Article

Academy

Scientists

Interview

Science and research

Video

The Czech Advanced Technology and Research Institute (CATRIN) at Palacký University is a cutting-edge scientific hub dedicated to advancing research in the fields of nanotechnology, biotechnology, and biomedicine. At its core, CATRIN boasts outstanding scientific teams, featuring international researchers. We emphasize interdisciplinarity, foster global collaborations, and work to translate our research findings into practical applications.

CATRIN

Phenomenex is a global technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers in industrial, government and academic laboratories.

Phenomenex

Organomation, founded in 1959, designs and manufactures high-quality nitrogen evaporators and extraction systems. Known for innovation and durability, their lab instruments are used globally for efficient sample preparation with strong customer support.

Organomation

Agilent Technologies

Technology Networks

SelectScience

SCIEX

Waters Corporation

Advanced materials are increasingly finding uses in the worlds of wafers and photovoltaic materials.
As they are being developed, there is a need to understand their optical properties. How much light is being reflected/transmitted/adsorbed and how the polarization of light effects these values gives insight into the materials’ potential performance in devices. This talk will examine how angular measurements can be made through the use of a Cary 7000 and its UMA (Universal Measurement Accessory).
<blockquote>
Presenter: Mark Fisher, PhD (Application Engineer, Molecular Spectroscopy, Agilent Technologies, Inc.)
</blockquote>
<blockquote>
Mark, an Application Scientist for Agilent Technologies, has over 35 years of experience in molecular spectroscopy. He has held roles in Agilent&#39;s UV-Vis-NIR, fluorescence, and atomic absorption product portfolios. In addition to identifying industry trends and new business needs, Mark&#39;s responsibilities include application development, pre and post-sales support, as well as acting as a customer advocate for new product and technology opportunities. Mark received his doctorate in analytical chemistry from the University of Nebraska-Lincoln.
</blockquote>

Agilent Technologies: Determination of Optical Properties of Advanced Materials through Angular UV-Vis-NIR Measurements

Determination of Optical Properties of Advanced Materials through Angular UV-Vis-NIR Measurements

How angular measurements can be made through the use of a Cary 7000 and its UMA (Universal Measurement Accessory).

Determination of Optical Properties of Advanced Materials

During this webinar we will be exploring the current challenges faced with glycan analysis, learn how to develop comprehensive workflow-based solutions with reduced sample preparation and analysis using the new GlycoWorks RapiFluor-MS Eco Labeling Kits (with DMSO as the Labeling Reagent Solvent) and tips and tricks to achieve accurate identification, sensitive and reproducible results for glycan analysis.
<blockquote>
Presenter: Stephan M. Koza, Ph.D. (Research &amp; Development, Waters Corporation)
</blockquote>
<blockquote>
Stephan has worked at Waters Corporation for twelve years and has a primary focus on the development and use of LC, LC-MS, and sample preparation chemistries for the analysis of biomolecules. Prior to joining Waters, he had nearly twenty years of experience with biopharmaceutical characterization and analytical method development with Genetics Institute, Wyeth, and Pfizer. Stephan received his graduate degree in Analytical Chemistry at the University of New Hampshire.
</blockquote>

Waters Corporation: Simplified Workflows for Glycan Analysis Combining Speed, Simplicity, and Unrivaled Sensitivity

Simplified Workflows for Glycan Analysis Combining Speed, Simplicity, and Unrivaled Sensitivity

Current challenges faced with glycan analysis, learn how to develop comprehensive workflow-based solutions.

Simplified Workflows for Glycan Analysis

LC-MS has been used for biopharmaceutical analysis for over 20 years and, in recent years, the demands of the industry have expanded significantly for this technique. This is due to drug classes expanding from monoclonal antibodies (mAbs) to include oligonucleotide and mRNA therapies, as well as novel protein-based drugs.
This webinar series explores the pivotal role of LC-MS in biopharmaceutical development, outlining the use of LC-MS for host cell protein impurity analysis, the capabilities of the ZenoTOF 7600 system for protein characterization, and the application of LC-MS in oligonucleotide and mRNA lipid nanoparticle analysis. These webinars provide crucial insights into the evolving landscape of LC-MS technology, highlighting it as an indispensable tool for ensuring the safety, efficacy, and purity of the next generation of life-saving drugs.
<h4>Session 3: Enhancing the characterization of mRNA lipid nanoparticle drugs and vaccines with new LC-MS solutions</h4>
In this webinar discover how a quadrupole time-of-flight (QTOF) system can be used for high-resolution quantitation of oligonucleotides. Understand how advancements in MS/MS scanning sensitivity and quantification, coupled with user-friendly software solutions, facilitate the identification of impurities, and enhance the characterization of oligonucleotides. Plus, learn about the application of LCMS/MS in conjunction with ion pairing or HILIC chromatography for detecting oligonucleotides in biological extracts.
In addition, explore the transformation of oligonucleotides into larger RNA sized molecules, and discover the role of LCMS in characterizing these expanded molecules, as well as the lipid nanoparticles utilized as carriers for these novel drugs.
<blockquote>
Presenter: Thomas Kofoed, PhD (Co-founder and CEO, Alphalyse)
</blockquote>
<blockquote>
Dr. Thomas Kofoed holds a PhD in Organic Chemistry and a BSc in Business Administration. He has over 15 years of management experience in the biotech industry and has set up business relationships with hundreds of biopharmaceutical companies. As CEO of Alphalyse, his main focus is putting together a diverse team of highly skilled employees creating an innovative environment focusing on quality and customer needs.
</blockquote>
<blockquote>
Presenter: Dr. Angela Fernandez (Mass Spectrometry Team Leader &amp; Project Manager, Leanbio Pro)
</blockquote>
<blockquote>
Dr. Angela Fernandez has a PhD in Biochemistry and Molecular Biology, and over a decade of experience in research and development in the biopharmaceutical industry and academia. Her expertise working in contract research organization (CRO) and CDMO companies includes biophysical and biochemical techniques for protein characterization, mass spectrometry-based analysis of new biological entities, and a comprehensive knowledge of drug development processes in a regulatory environment. Dr. Fernandez has established a new mass spectrometry platform from inception, expanding Leanbio&#39;s service offerings.
</blockquote>
<blockquote>
Presenter: Stephen Lock, PhD (Senior Market Development Manager, Biopharma, SCIEX™)
</blockquote>
<blockquote>
Dr. Stephen Lock obtained his PhD in Physical Organic Chemistry from the University College of Swansea and is a chartered chemist and a member of the Royal Society of Chemistry. He has worked for SCIEX™ in various technical roles for over 25 years, and is currently the EMEAI BioPharma Senior Market Development Manager. He is also an Adjunct Professor at the University of Pannonia where he acts in a volunteer role as a Scientific Advisor for the Horváth Csaba Memorial Laboratory, where he provides technical advice and supports the group’s fundamental research and development of new applications for capillary electrophoresis.
</blockquote>
<blockquote>
Presenter: Dr. Carrie Haslam (Associate Editor, SelectScience)
</blockquote>
<blockquote>
Dr. Carrie Haslam is an Associate Editor at SelectScience, playing a key role in content production and specializing in Materials Science, Alzheimer’s disease and Clinical Diagnostics. Carrie completed a Ph.D. from The University of Plymouth, where she developed graphene-based biosensors for the early diagnosis of Alzheimer’s disease.
</blockquote>

SelectScience: Mastering LC-MS in biopharmaceutical analysis - Session 3: Enhancing the characterization of mRNA lipid nanoparticle drugs and vaccines with new LC-MS solutions

Enhancing the characterization of mRNA lipid nanoparticle drugs and vaccines with new LC-MS solutions

Characterization of mRNA lipid nanoparticles with LC-MS

In this webinar, Dr. Stephanie Marin, Global Clinical Market Development Manager at Phenomenex, will provide a comprehensive overview of mixed-mode polymeric extraction (SPE) fundamentals and the properties of polymeric hydrophobic interaction (reversed-phase) SPE sorbents.
Attendees will learn how to choose the appropriate SPE phase for their specific compounds of interest, along with an explanation of the ionic functional groups that provide the mixed-mode functionalities, including both weak and strong cation and anion exchange.
Dr. Marin will also delve into the initial extraction conditions required to initiate method development for each type of SPE sorbent, as well as specialized SPE products tailored for drug testing, phospholipid removal, and microelution SPE. This webinar will include numerous clinical research applications to exemplify these concepts.
Key learning objectives
<ul>
<li>Discover how to differentiate different polymeric mixed-mode SPE extraction sorbents
</li>
<li>Explore starting conditions for each sorbent type
</li>
<li>Learn how to choose the best SPE sorbent for different analytes
</li>
<li>Understand how to use an SPE method development plate
</li>
</ul>
Who should attend?
<ul>
<li>Scientists doing SPE method development
</li>
<li>Labratorians who want to increase their knowledge of polymeric mixed-mode SPE
</li>
<li>Lab managers who want to implement SPE methods in their laboratories
</li>
</ul>
<blockquote>
Presenter: Dr. Stephanie J. Marin (Phenomenex)
</blockquote>

SelectScience: How to advance clinical research with polymeric mixed-mode solid phase extraction

How to advance clinical research with polymeric mixed-mode solid phase extraction

Mixed-mode polymeric extraction (SPE) fundamentals and the properties of polymeric hydrophobic interaction (reversed-phase) SPE sorbents.

Clinical research with polymeric mixed-mode SPE

Implementation of automated liquid handling has been instrumental in moving the use of metabolite biomarkers from bench to bedside.
In this webinar, you’ll hear how automated liquid handling for LC-MS/MS sample preparation contributed to the identification and quantification of over 30 metabolites that can predict adverse pregnancy outcomes, including pre-eclampsia.
Our expert speakers will also address how to achieve accurate and precise liquid handling, a must when creating volume-controlled blood samples for use in translational research.
Attend this webinar to:
<ul>
<li>Hear how fast, multiplexed metabolite determinations are made feasible with LC-MS/MS
</li>
<li>Discover the key requirements in LC-MS/MS based translational research 
</li>
<li>Explore the impact of the BRAVO liquid handling robot in metabolomic diagnostics 
</li>
<li>Learn how a robust, automated sample preparation protocol was developed to analyze multiple metabolites
</li>
</ul>
<blockquote>
Presenter: Leslie Brown (Senior Scientist, Metabolomic Diagnostics)
</blockquote>
<blockquote>
Presenter: Catherine Brown (Development Analyst, Metabolomic Diagnostics)
</blockquote>
<blockquote>
Presenter: Dr. Robin Tuytten (CEO Acting CSO, Metabolomic Diagnostics)
</blockquote>

Technology Networks: The Impact of Reliable Automation in Translational Metabolomics

The Impact of Reliable Automation in Translational Metabolomics

How automated liquid handling for LC-MS/MS sample preparation contributed to the identification and quantification of over 30 metabolites.

Reliable Automation in Translational Metabolomics

Key Learning Points:
<ul>
<li>Learn how to implement lean principles into your lab
</li>
<li>Pick up how to expand your testing capabilities without losing efficiency
</li>
<li>Take a deep dive into the impact of optimizing a standard method for ASB compliance testing
</li>
</ul>
Who Should Attend:
<ul>
<li>Any Forensic toxicologists who are interested in learning about whole blood and urine testing applications for medicolegal death, driving impairment, and drug-facilitated crime investigations.</li>
</ul>
<blockquote>
Presenter: Jeffery Moran, PhD (Chief Executive Officer, PinPoint Testing)
</blockquote>
<blockquote>
Dr. Jeffery Moran is the Chief Executive Officer at PinPoint Testing and has over 20 years’ experience in developing advanced testing applications including drug toxicology, industrial hygiene, and environmental threats. Dr. Moran has intimate knowledge of managing public health laboratories with over 10 years’ experience as the Branch Chief at the Arkansas Department of Health -Public Health Laboratory (ADH-PHL) where he managed A2LA-ISO17025, CAP/CMS-CLIA, and USEPA accredited laboratories. While at ADH-PHL Dr. Moran helped develop LC-MS/MS methods and validation plans for public health laboratories as part of the CDC Laboratory Response Network (LRN-C) and was often invited to serve as a technical expert. He chaired a national committee of experts to author the CLIA-Compliant Analytical Method Validation Plan and Template – for LRN-C Laboratories (Appendix E). Dr. Moran is a pioneer in the detection of novel psychoactive substances, publishing some of the first papers on the detection and metabolism of synthetic cannabinoids, opioids, and other designer drugs. Dr. Moran continues research on designer drugs as an assistant professor at the University of Arkansas for Medical Sciences in the Department of Pharmacology and Toxicology. He is a qualified expert witness that specializes in analytical toxicology and drug metabolism. 
</blockquote>

Phenomenex: ASB/OSAC Compliance Testing – One Box, One Analyst, One Instrument

ASB/OSAC Compliance Testing – One Box, One Analyst, One Instrument 

ASB/OSAC Compliance Testing

The two major biologically active estrogens in non-pregnant humans are 17β-estradiol (E2) and estrone (E1). E2 is produced primarily in the ovaries and testes by the aromatization of testosterone, whereas most of E1 is derived from androstenedione. E2 can be metabolized to E1 and conversion of E1 to E2 is also possible, making the measurement of both compounds desirable.
The greatest challenge when analyzing E2 and E1 is the requirement to measure down to low concentration levels for certain clinical research applications. Currently, some immunoassay techniques lack analytical sensitivity and more commonly selectivity, while published LC-MS/MS methods use large sample volumes with complex sample extraction, often including derivatization.
The aim of this presentation is to demonstrate the performance of the <a href="https://lcms.cz/products/199">ACQUITY UPLC™ I-Class</a> and <a href="https://lcms.cz/products/554">Xevo™ TQ-Absolute</a> for the quantification of estrogens for clinical research. 
During this presentation you will also learn about the importance of chromatographic separation of isotopic species, and choice of internal standard to compensate for matrix effects and how to measure them.
<blockquote>
Presenter: Robert Wardle (Senior Scientist, Waters Corporation)
Robert Wardle is currently a Senior Scientist with the Clinical Business Unit at Waters Corporation in Wilmslow, UK, performing research and development of applications and products for Clinical Research. His primary area of research is vitamins and in particular vitamin D metabolites, steroid hormones and in-depth knowledge of offline and online automation.
Robert joined Waters in 2010, playing a key role in reagent Kit verification activities before moving on to developing LC-MS/MS methods for a range of applications including vitamin D metabolites, estrogens and a large panel of steroid hormones, where he also included the complete LC-MS/MS workflow of these application areas through offline automation and LIMS integration.
</blockquote>

Waters Corporation: [Webinar Week]: Innovations and Applications for the Clinical Workflow

LC-MS/MS Analysis of Serum Estrogens for Clinical Research

Demonstration of the ACQUITY UPLC™ I-Class and Xevo™ TQ-Absolute performance for the quantification of estrogens in clinical research.

Join us for an exceptional live event that will take you behind the scenes of technotes, with insights and expertise from three remarkable speakers. Get ready to ignite your curiosity and expand your knowledge in this unique webinar experience.
<h4>Webinar highlights:</h4>
Technical note 1: Development of an acetylcholinesterase biochemical assay using the SCIEX Echo® MS system (Speaker: Jacob MacCabe)
<ul>
<li>Discover the critical role of biochemical assays in drug discovery, their significance in evaluating safety liabilities, and how mass spectrometry revolutionizes enzyme target screening. Jacob MacCabe, a senior scientist at SCIEX, will unveil the power of the SCIEX Echo MS system in a routine acetylcholinesterase (AChE) biochemical safety assay.</li>
</ul>
Technical note 2: Enhanced drug metabolite identification using collision-induced dissociation (CID) and electron-activated dissociation (EAD) (Speaker: Rahul Baghla/ Eshani Nandita Galermo)
<ul>
<li>Learn about a software-assisted approach for metabolite identification using the ZenoTOF 7600 system and Molecule Profiler software. By combining CID and EAD data, our speakers will show you how to increase confidence in metabolite structure assignments.</li>
</ul>
Technical note 3: A sensitive method for the quantitation of bimatoprost in human plasma (Speaker: Lakshmanan Deenadayalan)
<ul>
<li>Uncover a highly sensitive method for quantifying the ocular drug, bimatoprost, in human plasma. Lakshmanan Deenadayalan, an Application Support Specialist at the Indian Innovation Center (IIC), SCIEX, will demonstrate a simple liquid-liquid extraction sample preparation that achieves a lower limit of quantitation (LLOQ) of 0.5 pg/mL with %CV &lt; 3%.</li>
</ul>
<blockquote>
Presenter: Rahul Baghla (M. Pharma, MBA, Manager Pharma Applications, SCIEX)
</blockquote>
<blockquote>
Presenter: Lakshmanan Deenadayalan (Application Support Specialist, Indian Innovation Center (IIC), SCIEX)
</blockquote>
<blockquote>
Presenter: Eshani Nandita (Global Biopharma Quant Tech Marketing Lead, SCIEX)
</blockquote>
<blockquote>
Presenter: Jacob W. McCabe (Senior scientist at SCIEX specializing in the Echo MS system)
</blockquote>

SCIEX: Chapter 3: Inside the technical note

Chapter 3: Inside the technical note

Join us for a live event that will take you behind the scenes of technotes. 

Inside the SCIEX technical note

Unearthing novel drug targets with robust data support and a deep understanding of biological processes remains a pivotal challenge in drug discovery. 
In this engaging webinar, distinguished speakers Aaron Mitchell and Rasmus Wernersson from ZS Associates will unveil a comprehensive method that significantly enhances target prediction performance through the integration of multiomics data, coupled with a data-driven, cell-type specific network biology approach.
Gain practical insights and a deeper understanding of cutting-edge methodologies as Aaron and Rasmus delve into the theoretical underpinnings of network biology, presenting tangible workflows and performance benchmarks derived from recent projects. 
By attending this webinar, you will: 
<ul>
<li>Learn about the approaches and biological considerations for integration across heterogenous multiomics data sets
</li>
<li>Discover approaches for benchmarking genome-wide drug target prioritization
</li>
<li>Navigate the critical decision points in constructing cell-type specific networks and pathways
</li>
<li>Grasp the difference between “single gene” level and “system” level analysis
</li>
</ul>
<blockquote>
Presenter: Aaron Mitchell (Life Sciences R&amp;D and Medical Area Lead, ZS)
</blockquote>
<blockquote>
Presenter: Rasmus Wernersson (Discovery Scientific Lead, ZS)
</blockquote>

Technology Networks: Innovations in Multiomics Research for Life Sciences

Innovations in Multiomics Research for Life Sciences

This webinar will unveil a comprehensive method that significantly enhances drug target prediction performance through the integration of multiomics data.

In this session we show you how you streamline your documentation and replace paper by electronic recording

Waters Corporation: Waters Empower LMS Inventories

Empower LMS Inventories